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Oxidative stress causes mitochondrial fragmentation and dys-
function in age-related diseases through unknown mechanisms.
Cardiolipin (CL) is a phospholipid required for mitochondrial
oxidative phosphorylation. The function of CL is determined by
its acyl composition, which is signiﬁcantly altered by the onset
of age-related diseases. Here, we examine a role of acyl-CoA:
lysocardiolipin acyltransferase lysocardiolipin acyltransferase 1
(ALCAT1), a lysocardiolipin acyltransferase that catalyzes patho-
logical CL remodeling, in mitochondrial biogenesis. We show that
overexpression of ALCAT1 causes mitochondrial fragmentation
through oxidative stress and depletion of mitofusin mitofusin 2
(MFN2) expression. Strikingly, ALCAT1 overexpression also leads
to mtDNA instability and depletion that are reminiscent of MFN2
deﬁciency. Accordingly, expression of MFN2 completely rescues
mitochondrial fusion defect and respiratory dysfunction. Further-
more, ablation of ALCAT1 prevents mitochondrial fragmentation
from oxidative stress by up-regulating MFN2 expression, mtDNA
copy number, and mtDNA ﬁdelity. Together, these ﬁndings reveal
an unexpected role of CL remodeling in mitochondrial biogenesis,
linking oxidative stress by ALCAT1 to mitochondrial fusion defect.
Oxidative stress causes mitochondrial dysfunction, which hasbeen implicated in aging and age-related diseases (1–3).
Although the underlying causes remain elusive, disrupted mito-
chondrial dynamics by reactive oxygen species (ROS) has been
implicated in mitochondrial pathogenesis in these conditions
(4–6). The onset of diabetes is associated with mitochondrial
fragmentation in islet β-cells, endothelial cells, and neurons at-
tributable to a fusion defect (4–6). Hyperglycemia causes rapid
mitochondrial fragmentation concurrently with increased ROS
production (7). Consequently, inhibition of mitochondrial ﬁssion
prevented periodic ﬂuctuation of ROS production during high
glucose exposure (7). Furthermore, oxidative stress and mito-
chondrial fragmentation have also been implicated in neurode-
generative diseases, which are often associated with diabetic
complications (8).
Mitofusin 2 (MFN2) encodes a mitochondrial protein that is
required for mitochondrial integrity, fusion, metabolism, and
tethering with endoplasmic reticulum (ER) (9). Mutations in
MFN2 in humans cause peripheral neuropathy and Charcot–
Marie–Tooth disease. MFN2 deﬁciency is also implicated in
mitochondrial dysfunction associated with obesity and type 2
diabetes. Muscle MFN2 expression is reduced in type 2 diabetic
patients (10). MFN2 expression negatively correlates with obe-
sity and positively correlates with insulin sensitivity (10). Ame-
lioration of insulin resistance in type 2 diabetes by bariatric
surgery increases MFN2 expression in muscle. Likewise, mod-
erate physical exercise, which is known to improve insulin sen-
sitivity, signiﬁcantly increases MFN2 expression and mitochondrial
biogenesis (11). Additionally, targeted deletion of MFN2 in mouse
skeletal muscle causes mtDNA instability and high mutation rates,
leading to severe mtDNA depletion (9).
Cardiolipin (CL) is a key mitochondrial phospholipid required
for oxidative phosphorylation. CL is highly sensitive to oxidative
damage of its double bonds by ROS because of its rich content
in linoleic acid and location near the site of ROS production in
the inner mitochondria membrane, a process also known as CL
peroxidation (12). CL is the only phospholipid in mitochondria
that undergoes early oxidation during apoptosis, which triggers
the release of cytochrome c to cytosol, leading to apoptotic
consumption (12). Consequently, abnormal CL acyl composition
from pathological remodeling has been implicated in the etiology
of mitochondrial dysfunction commonly associated with diabetes
(13), obesity (2), cardiovascular diseases (14), neurological disorders
(5), cancer (15), aging (16), and other age-related diseases (17).
Acyl-CoA:lysocardiolipin acyltransferase 1 (ALCAT1) is a
lysocardiolipin acyltransferase that was recently identiﬁed to
catalyze pathological remodeling of CL in response to oxidative
stress in diabetes, obesity, and cardiomyopathy, leading to ROS
production, mitochondrial dysfunction, and insulin resistance (2,
18). CL remodeling by ALCAT1 also results in CL deﬁciency
and changes of CL acyl composition that are reminiscent of age-
related diseases, including depletion of linoleic acid and enrich-
ment of docosahexaenoic acid (DHA) content in CL. Targeted
inactivation of ALCAT1 prevents the onset of diet-induced
obesity and its related metabolic complications (2). The present
investigation sought to advance our understanding of molecular
mechanisms by which ALCAT1 regulates mitochondrial dys-
function associated with oxidative stress. In the process, we de-
scribe an unexpected role of ALCAT1 in regulating mitochon-
drial fusion and mtDNA ﬁdelity, implicating a critical role of
ALCAT1 in MFN2 deﬁciency and mitochondrial fragmentation
in age-related diseases.
Results
ALCAT1 Causes Mitochondrial Fragmentation and mtDNA Instability
in C2C12 Cells. To investigate a role of ALCAT1 overexpression in
regulating mitochondria and ER morphology, we generated
C2C12 cell lines stably transfected with ﬂag-tagged ALCAT1
cDNA (C2C12-A1) or vector control (C2C12-V). The mRNA
expression level of ALCAT1 in the C2C12-A1 cells is only
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threefold higher than the C2C12-V cells (Fig. S1) and matches
the level of ALCAT1 expression induced by the onset of diabetes
and obesity (2). Using the stable cells as a cell based model, we
showed ALCAT1 overexpression caused mitochondrial frag-
mentation (Fig. 1 A and B; quantiﬁed in Fig. 1C) and mito-
chondrial swelling (Fig. 1 D and E; highlighted in Fig. 1 F and
G), as analyzed by confocal and electron microscopic (EM)
analysis. Furthermore, ALCAT1 overexpression also caused se-
vere ER dilation, as highlighted by white dashed lines (Fig. 1 F
and G), consistent with previously reported localization of
ALCAT1 at mitochondria-associated membrane (MAM) (2).
Remarkably, ALCAT1 overexpression also signiﬁcantly depleted
mtDNA copy number in C2C12-A1 cells (Fig. 1H) and increased
mtDNA mutation rate (Fig. 1I), suggesting a major role of
ALCAT1 in regulating mitochondrial mass and mtDNA stability.
Ablation of ALCAT1 Increases Mitochondrial Mass and mtDNA Fidelity
in Mice.Using ALCAT1 knockout (KO) mice recently generated
in our laboratory (2), we analyzed the effect of ALCAT1 de-
ﬁciency on mitochondrial morphology, mtDNA mass, and
mtDNA mutation rate in isolated mouse embryonic ﬁbroblasts
(MEFs) and skeletal muscles by EM analysis. In support of the
ﬁndings in the C2C12 cells, ALCAT1 deﬁciency signiﬁcantly
increased mitochondrial density (Fig. 2 A and B; highlighted in
Fig. 2 C and D). Ablation of ALCAT1 signiﬁcantly increased
thickness of the skeletal muscle ﬁber, as evidenced by the en-
larged dark A bands and light I bands (Fig. 2 E and F; quantiﬁed
in Fig. S2). Furthermore, ablation of ALCAT1 signiﬁcantly in-
creased mtDNA copy number and mtDNA ﬁdelity, as evidenced
by signiﬁcantly lower mtDNA mutation rate in the isolated
MEFs from ALCAT1 KO mice (Fig. 2 G and H).
Key Role of ALCAT1 in Regulating MFN2 Expression. MFN2 is re-
quired for mitochondrial and ER morphology and tethering as
a functional bridge (19). MEFs from MFN2−/− mice display
fragmented mitochondria and dilated ER cisternae that re-
semble the defects caused by in ALCAT1 overexpression (19).
We, thus, asked whether ALCAT1 overexpression and deﬁciency
would reciprocally affect the expression of MFN2 and other
regulators of the mitochondrial fusion process. As shown in Fig.
3A, ALCAT1 overexpression caused a >70% depletion of MFN2
mRNA and a 50% reduction of both MFN1 and optic atrophy
(OPA)1 mRNAs in the C2C12-A1 stable cell line compared with
vector control. Conversely, ALCAT1 deﬁciency dramatically in-
creased transcription of MFN2 mRNA concurrently with a
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Fig. 1. ALCAT1 causes mitochondrial fragmentation and mtDNA instability
in C2C12 cells. (A and B) Confocal microscopic analysis of mitochondrial
network in C2C12 cells stably expressing ALCAT1 (B) or vector control (A)
stained with MitoTracker Red. Insets represent magniﬁcation of the boxed
areas. (Scale bars: 5 μm.) (C) Quantitative analysis of mitochondrial mor-
phology in C2C12 cells expressing ALCAT1 or vector control in three cate-
gories: tubular, mix, and fragmented from three independent experiments
(n = 300). (D–G) EM analysis of mitochondrial morphology in C2C12 cells
stably expressing vector control (D; enlarged in F ) or ALCAT1 (E; enlarged in
G). ER morphology is highlighted by dashed lines. (Scale bars: 1 μm.) (H and
I) RT-PCR analysis of mtDNA copy number (H) and point mutation rate (I)
in C2C12 cells stably expressing ALCAT1 or vector control. *P < 0.05; **P <
0.01 (n = 3). N, nucleus; M, mitochondria.
Fig. 2. ALCAT1 deﬁciency signiﬁcantly increases mitochondrial mass and
improves mtDNA ﬁdelity. (A–D) EM analysis of mitochondrial morphology
of MEF cells isolated from wild-type (WT) control mice (A; enlarged in C)
and from ALCAT1 KO mice (B; enlarged in D). (E and F) EM analysis of
the tibialis anterior longitudinal section from WT mice (E) and ALCAT1 KO
mice (F). Arrows indicate A band, I bands, Z line, and mitochondria (M),
respectively. (G and H) RT-PCR analysis of mtDNA copy number (G) and point
mutation rate (H) in MEF cells isolated from KO mice and the WT controls.
**P < 0.01 (n = 3).
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signiﬁcant increase in MFN1 mRNA level in isolated MEFs from
ALCAT1 KO mice (Fig. 3B). However, ALCAT1 deﬁciency did
not have any effect on mRNA expression of OPA1, which is re-
quired for the fusion of inner mitochondrial membrane.
Consistent with decreased mRNA levels, expression all of
the three proteins were also signiﬁcantly down-regulated by
ALCAT1 overexpression (Fig. 3C). Conversely, MFN2 protein
level was up-regulated by >600% in MEFs isolated from the
ALCAT1 KO mice when normalized by the expression of OPA1,
which is used as a marker for mitochondrial mass (Fig. 3D;
quantiﬁed in Fig. 3E). ALCAT1 deﬁciency also signiﬁcantly in-
creased the expression of MFN1 and prohibitin, a mitochondrial
membrane chaperone protein required for optimal mitochon-
drial morphology and respiration. In contrast, ALCAT1 de-
ﬁciency did not affect the expression of OPA1 or calnexin, an
ER resident protein (Fig. 3E). Finally, consistent with a caus-
ative role of ALCAT1 in oxidative stress, ALCAT1 negatively
regulated the expression of voltage-dependent anion channel
(VDAC)1, a voltage-dependent anion channel protein in the
outer mitochondrial membrane that regulates ROS release from
the intermembrane space to the cytosol (20) (Fig. 3 C and D).
ALCAT1 Impairs Mitochondrial Fusion Through MFN2 Depletion.
The ﬁndings that ALCAT1 causes MFN2 depletion and mito-
chondrial fragmentation prompted us to investigate a role of
ALCAT1 in regulating mitochondrial fusion. Mitochondrial
matrix-targeted EGFP (mtEGFP) or red ﬂuorescent protein
(mtRFP) was individually transfected in C2C12-A1 and C2C12-
V2 cells, followed by fusion analysis by measuring overlay of the
EGFP and RFP under a confocal microscope. As shown in Fig. 4
A–C, mitochondria in the vector control C2C12 cells demon-
strated normal mitochondrial fusion, as evidenced by the yellow
color of the merged image in Fig. 4C (highlighted in Fig. 4D),
which suggests a complete fusion. In contrast, ALCAT1 over-
expression in C2C12 cells caused a severe fusion defect (Fig. 4
E–H), as evidenced by well-separated green and red colors of the
merged image in Fig. 4G (highlighted in Fig. 4H). In direct
support of a causative role of MFN2 deﬁciency in the fusion
defect, transient expression of MFN2 in C2C12-A1 cells com-
pletely rescued the fusion defect, as supported by the yellow
color of the merged image in Fig. 4K (highlighted in Fig. 4L).
MFN2 expression also caused super fusion of mitochondria,
which is supported by thicker mitochondrial tubular network in
C2C12-A cells overexpressing MFN2 (Fig. 4 I–K). The results
are consistent with the previously reported effect of MFN2 on
super fusion in various cell types (21).
MFN1/2, but Not OPA1, Rescues Mitochondrial Fragmentation Caused
by ALCAT1.Because MFN2 can rescue the fusion defect caused by
ALCAT1, we questioned whether other members of the dyna-
min-related family, such as MFN1 and OPA1, could also rescue
fusion defect by restoring mitochondrial network in the C2C12-
A1 cells. In contrast to C2C12-A1 cells, which exhibit mito-
chondrial fragmentation (Fig. 5 C and D), transient expression of
MFN1 in C2C12-A1 cells almost completely rescued the fusion
defect, as shown by the recovery of the tubular mitochondria
(Fig. 5 E and F) similar to vector control cells (Fig. 5 A and B).
Again, transient expression of MFN2 completely rescued the
fusion defect, leading to superfusion of mitochondria (Fig. 5 G
and H). In contrast, transient expression of OPA1 failed to
rescue any of the fusion defect (Fig. 5 I and J), which is consistent
with a lack of any effect of ALCAT1 deﬁciency on OPA1 ex-
pression in MEFs (Fig. 3 B–E). The results suggest that the
ALCAT1-mediated fusion defect is limited to the outer mito-
chondrial membrane, which is closely associated with MAM,
where ALCAT1 is localized (2).
MFN2 Rescues Mitochondrial Respiratory Defects Caused by ALCAT1
Overexpression. ALCAT1 causes mitochondrial dysfunction and
mitochondrial proton leakage, which is likely a compensatory
response to oxidative stress, leading to increased oxygen con-
sumption rate (OCR) (2). We, therefore, interrogated a role of
MFN2 expression in regulating OCR of cultured C2C12-A1 cells
in response to treatments with different mitochondrial inhibitors.
Using the Seahorse Extracellular Flux (XF-24; Seahorse Bio-
science) analyzer, we show transient expression of MFN2, but
not EGFP vector control, completely restored mitochondrial
respiratory capacity, as evidenced by the recovery of OCR rela-
tive to vector control in response to FCCP (Fig. 6A). Consistent
with complex I as the major site for ROS production, ALCAT1
overexpression signiﬁcantly increased OCR in response to treat-
ment with rotenone, an inhibitor of complex I (NADH CoQ1
reductase), which is also normalized by transient expression
of MFN2 in C2C12-A1 cells (Fig. 6B). Consistent with in-
creased proton leakage, ALCAT1 overexpression also signiﬁcantly
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Fig. 3. ALCAT1 regulates biogenesis of MFN1 and MFN2. (A and B) Real-
time PCR analysis of mRNA expression levels of MFN1, MFN2, and OPA1 in
C2C12 cells stably expressing ALCAT1 or vector control (A) and in MEFs iso-
lated from WT and KO mice (B). GAPDH expression was used as an internal
control. (C) Western blot analysis of MFN1, MFN2, OPA1, and VDAC1 protein
levels in C2C12 cells expressing ALCAT1 or vector control. Relative density of
each band was shown under each lane. (D) Western blot analysis of protein
levels of MFN1, MFN2, OPA1, calnexin, prohibitin, and VDAC1 in MEFs iso-
lated from KO and WT control mice (n = 3 fetuses in each group). (E)
Quantitative analysis of data shown in E after normalization with the ex-
pression level of OPA1. **P < 0.01 compared with vector control or WT
control mice.
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increased OCR in response to treatment with oligomycin, a mito-
chondrial ATPase inhibitor. Likewise, such a defect can also be
completely normalized by transient expression of MFN2 (Fig. 6D).
In contrast, neither ALCAT1 nor MFN expression had any effect
on OCR from complex III, in response to treatment with anti-
mycin, a complex III inhibitor, as previously reported (2).
ALCAT1 Links Oxidative Stress to Mitochondrial Fragmentation and
MFN2 Deﬁciency. Impaired mitochondrial fusion from oxidative
stress causes mitochondrial swelling by opening the mitochon-
drial permeability transition pore (22). Damaged mitochondria
often generate more ROS which further exacerbate mitochon-
drial dysfunction, leading to a vicious cycle (23). Because CL
remodeling by ALCAT1 causes oxidative stress, we questioned
whether ALCAT1 played a role in the vicious cycle, which was
tested in isolated MEFs from ALCAT1 KO and control mice. As
shown in Fig. 7A (highlighted in Fig. 7C), MEFs from control
mice exhibit severe mitochondrial swelling in response to treat-
ment with H2O2, as evidenced by enlarged mitochondria and
damaged cristae. Likewise, ALCAT1 overexpression also caused
severe mitochondrial swelling in one of the C2C12 stable cell lines
that exhibits the highest expression of ALCAT1 relative to the
vector controls (Fig. S3). Because of this extreme feature, this
C2C12 cell line was not used for the current studies. In contrast,
ALCAT1 deﬁciency completely preventedmitochondrial swelling
(Fig. 7B; highlighted in Fig. 7D) and mitochondrial fragmentation
in isolated MEFs in response to treatment of H2O2 (Fig. S4).
In direct support of a causative role of ALCAT1 in oxidative
stress, ALCAT1 overexpression signiﬁcantly increased H2O2
production in C2C12-A1 cells (Fig. 7E). Consequently, ALCAT1
overexpression also caused severe lipid peroxidation, which was
further exacerbated in response to treatment with increased
doses of H2O2, as shown by elevated level of malondialdehyde
(MDA), an end product of lipid peroxidation (Fig. 7F). It was
previously reported that mitochondria undergo rapid fragmen-
tation concomitantly with an increase in ROS production (7). In
support of oxidative stress by ALCAT1 as the primary cause of
MFN depletion, treatment of C2C12-A1 and the vector control
cells with H2O2 dose-dependently depleted MFN1 and MFN2
expression (Fig. 7G), leading to a complete loss of MFN2 ex-
pression in C2C12-A1. Finally, in direct support of oxidative
stress by ALCAT1 as the primary cause of MFN depletion,
preincubation of the C2C12 cells with diphenyleneiodonium
(DPI), an antioxidant, dose-dependently prevented the loss of
MFN expression caused by H2O2 in C2C12-A1 cells (Fig. 7H)
and in vector control cells (Fig. S5).
Discussion
Dynamic networks are formed when mitochondria undergo a
fusion event that causes the compartments of participating mi-
tochondria to become continuous. The fusion event allows the
constituents of each network to share solutes, metabolites, and
proteins. Consequently, disruption of such networks causes oxi-
dative stress and mitochondrial fragmentation, which has been
implicated in the etiology of aging and age-related diseases (4–8,
24, 25). However, little is known about the underlying mechanisms.
Fig. 4. ALCAT1 impairs mitochondrial fusion, which can be rescued by
MFN2 expression in C2C12 cells. C2C12 cells stably expressing ALCAT1 or
vector control were transiently transfected with expression plasmid for mi-
tochondrial-targeted GFP or DsRed (mtRFP), coplated, and fused with PEG-
1500, followed by confocal microscopic imaging. (A–D) Confocal images of
mitochondria in C2C12 cells stably expressing vector control, which dem-
onstrated complete fusion, as evidenced by the yellow color in panel C and
highlighted in D. (E–H) Images of mitochondria in C2C12 cell stably
expressing ALCAT1, which exhibited a fusion defect, as shown by the sepa-
rated green and red colors in G and highlighted in H. (I–L) Transient ex-
pression of MFN2 (MFN2-YFP) rescued the fusion defect in C2C12 cells stably
expressing ALCAT1 (K; highlighted in L). (Scale bar: 5 μm.)
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Fig. 5. Overexpression of MFN1 and MFN2, but not OPA1, restores mito-
chondrial network in C2C12-A1 cells. (A–D) Confocal image analysis of mi-
tochondrial network in C2C12 cells stably expressing vector control (A and B)
or ALCAT1 (C and D). The stable C2C12 cell lines were transiently transfected
with mitochondrial-targeted EGFP expression vector (A and C) and stained
with MitoTracker Red (B and D) before imaging. (E–J) Confocal image
analysis of mitochondrial network in C2C12 cells stably expressing ALCAT1
and transiently transfected with expression vectors for Myc-tagged MFN1 (E
and F), MFN2-YFP (yellow ﬂuorescence protein) (G and H), or Myc-tagged
OPA1 (I and J), respectively. For the Myc-tagged proteins, cells were ﬁrst
stained with MitoTracker Red and then ﬁxed, followed sequentially by
immunostaining with mouse anti-Myc antibodies and goat anti-mouse FITC-
conjugated secondary antibodies (green). (Scale bar: 5 μm.)
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The current studies investigated a role of ALCAT1 in regulating
oxidative stress and mitochondrial fragmentation commonly as-
sociated with age-related metabolic diseases. We demonstrate
a critical role for ALCAT1 in regulating mitochondrial bio-
genesis and mtDNA ﬁdelity. Accordingly, ALCAT1 over-
expression severely impairs mitochondrial fusion, leading to
mitochondrial fragmentation and mtDNA depletion. Conversely,
targeted inactivation of ALCAT1 in mice signiﬁcantly increases
mitochondrial mass and protects mitochondria from ROS-in-
duced mitochondrial swelling and fragmentation. Strikingly, we
also demonstrate a key role of ALCAT1 in regulating mtDNA
ﬁdelity, which is corroborated by previous studies that mito-
chondrial fusion is required to safeguard mtDNA integrity (9).
In support of a role for ALCAT1 in mitochondrial fusion,
the current studies identiﬁed MFN2 as a downstream target of
ALCAT1-mediated mitochondrial dysfunction. MFN2 is re-
quired for mitochondrial fusion, tethering with ER, energy me-
tabolism, and mtDNA ﬁdelity in mammals (9, 19). We show that
ALCAT1 overexpression severely depleted MFN2 expression in
C2C12 cells, whereas ALCAT1 deﬁciency dramatically increased
MFN2 expression in isolated MEFs from ALCAT1 KO mice. In
contrast, ALCAT1 deﬁciency did not have any effect on ex-
pression of OPA1, which is required for fusion of the inner mi-
tochondrial membrane (26). The results suggest that ALCAT1
only affects the fusion of the outer mitochondrial membrane
which is closely associated with MAM, where ALCAT1 is
localized (2). The ﬁnding is further corroborated by a recent
report that 25% CL is also localized in the outer membrane
where active CL remodeling takes place (27). Consistent with
MFN2 as the downstream target of ALCAT1-mediated fusion
defect, targeted inactivation of MFN2 in mice causes multiple
mitochondrial defects that are reminiscent of ALCAT1 over-
expression, including high mtDNA mutation rate, mtDNA de-
pletion, fragmented mitochondria, and a profound loss of
tethering between mitochondria and ER (19, 28). A further study
showed that MFN2 deﬁciency also caused skeletal muscle atro-
phy, which is consistent with our ﬁnding that ALCAT1 deﬁciency
signiﬁcantly increased skeletal mass in ALCAT1 KO mice (2, 9).
In direct support of MFN2 as downstream target of ALCAT1,
the mitochondrial fusion defect caused by ALCAT1 can be
rescued by expression of either MFN1 or MFN2, but not by
OPA1. Furthermore, MFN2 expression also restored the mito-
chondrial respiratory capacity and reduced oxidative stress in
C2C12 cells overexpressing ALCAT1. These results are consis-
tent with a previous report that MFN2 deﬁciency signiﬁcantly
increases proton leakage (29), whereas overexpression of MFN2
blocks hyperglycemia-induced ROS production (7).
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Fig. 6. MFN2 restores the mitochondrial respiratory capacity in C2C12 cells
stably expressing ALCAT1. C2C12 cells stably expressing ALCAT1 were tran-
siently transfected with expression vectors for MFN2 or EGFP and were
compared with vector control for changes in OCR in response to treatment
with various mitochondrial inhibitors, including: FCCP, an mitochondrial
uncoupler (A); rotenone, a complex I inhibitor (B); antimycin, a complex III
inhibitor (C); and oligomycin, an ATPase inhibitor (D). The exogenous and
endogenous MFN2 protein levels were analyzed by Western blot analysis
using MFN2 antibodies, as shown in A. OCR was analyzed by Seahorse X-24
analyzer and calculated from at least three independent measurements
for each chemical treatment. *P < 0.05 compared with control; #P < 0.05 and
##P < 0.01 compared with nontransfected ALCAT1-expressing cells.
Fig. 7. Oxidative stress by ALCAT1 links ROS production to MFN2 deﬁciency.
(A–D) EM analysis of mitochondrial morphology in MEF from WT mice (A;
highlighted in C) or KO mice (B; highlighted in D) treated with 1 mM H2O2.
(E) Real-time production of H2O2 from isolated mitochondria from C2C12
cells overexpressing vector or ALCAT1. (F) C2C12 cells were treated with
indicated doses of H2O2 for 1 h, followed by analysis for the level of MDA,
a lipid peroxidation product from oxidative stress. (G) C2C12 cells stably
expressing vector control or ALCAT1 were treated with increasing doses of
H2O2 for 1 h as indicated in F, followed by Western blot analysis for MFN1
and MFN2 expression. (H) Western blot analysis of MFN1 and MFN2 ex-
pression in C2C12 cells stably expressing vector, ALCAT1, or ALCAT1 but
were pretreated for 1 h with increasing doses (0, 1, and 5 μM) of DPI, an
NADPH oxidase inhibitor, followed by treatment with 1.5 mM H2O2 for 1 h.
*P < 0.05; **P < 0.01 compared with vector control.
Li et al. PNAS | May 1, 2012 | vol. 109 | no. 18 | 6979
CE
LL
BI
O
LO
G
Y
It has been shown previously that mitochondrial ﬁssion/fusion
machinery controls acute and chronic production of ROS in
hyperglycemia-associated disorders (7). Mitochondria undergo
rapid fragmentation concomitantly with an increased ROS pro-
duction in response to oxidative stress, which can be mitigated
through inhibition of ﬁssion or stimulation of the fusion process
(30). The present studies identiﬁed ALCAT1 as a missing link
between mitochondrial fusion defect and ROS production in
metabolic diseases, which is supported by multiple lines of evidence.
First, CL remodeling by ALCAT1 signiﬁcantly increased DHA
content in CL, leading to proton leakage and oxidative stress (2,
18). This is likely the primary mechanism by which ALCAT1
regulates oxidative stress, because double bond content in mi-
tochondrial membrane phospholipids inversely correlates with
lifespan and positively correlated with ROS production and lipid
peroxidation index in mammals (31). Hence, increased DHA
content in CL increases lipid peroxidation index, which has been
implicated in mitochondrial dysfunction in aging and age-related
diseases (13, 14, 16, 32–34). Second, we show that ALCAT1
overexpression signiﬁcantly increased H2O2 production rate in
C2C12 cells. Consequently, ALCAT1 overexpression also caused
severe lipid peroxidation in C2C12 cells, which was further exac-
erbated by oxidative stress. Third, in direct support of oxidative
stress by ALCAT1 as the primary cause of the fusion defect,
ALCAT1 overexpression signiﬁcantly depleted MFN2 expression,
which can be mitigated by pretreatment of C2C12 cells with an
antioxidant. Finally, in support of a causative role of ALCAT1 in
the onset of age-related diseases, ALCAT1 expression is up-
regulated by oxidative stress and by the onset of age-related
metabolic diseases (2). Together, these ﬁndings support a key
role for ALCAT1 in linking ROS production to mitochondrial
fragmentation through depletion of MFN2 in age-related diseases,
as depicted by a schematic model in Fig. S6. Therefore, it can be
envisaged that development of chemical inhibitors forALCAT1may
provide a potential treatment for aging and age-related diseases in
the future.
Materials and Methods
The generation of the ALCAT1 KO mice and measurement of OCR were as
described previously (2). All experiments used littermate control of matched
age and sex and in accordance with approval of institutional animal care and
use protocols according to National Institutes of Health guidelines (35).
Confocal microscopy, EM analysis, mtDNA mutation assay, mitochondrial
fusion assay, MEF preparation, statistical analysis, and all of the reagents
used in this study were described in details in SI Materials and Methods.
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